Bio-Techne (TECH) insider trading

By person

25 insiders · 302 transactions

4.2×

Kim Kelderman holds only 4.2 times base salary in stock. $4.00M of shares against $936.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Kim Kelderman last reported holding, valued at $48.28, the price Common Stock was last bought or sold at on the open market here, on 8 May 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Hippel James

CFO

—

$60.15M (77) scheduled

−$60.15M

170,183

0.1087%

$8.22M

+300.0%

Kummeth Charles R.

Chief Executive Officer

$37.00K (2)

$52.19M (34) scheduled

−$52.16M

1,278,369

0.8165%

$61.72M

+63.4%

Eansor Norman David

President-Protein Sciences

—

$37.41M (30) scheduled

−$37.41M

2,117

0.0014%

$102.21K

−46.2%

Furlow Brenda S.

SVP - GENERAL COUNSEL

—

$22.52M (30) scheduled

−$22.52M

27,422

0.0175%

$1.32M

+35.9%

Nusse Roeland

Director

—

$8.55M (6) scheduled

−$8.55M

44,559

0.0285%

$2.15M

+135.1%

BAUMGARTNER ROBERT V

Director

$201.30K (2)

$8.50M (15) scheduled

−$8.29M

46,503

0.0297%

$2.25M

+24.4%

HIGGINS JOHN L

Director

—

$7.29M (14) scheduled

−$7.29M

66,876

0.0427%

$3.23M

+254.2%

STEER RANDOLPH C

Director

—

$7.10M (9) scheduled

−$7.10M

24,201

0.0155%

$1.17M

+27.4%

WIENS HAROLD J

Director

—

$3.44M (7) scheduled

−$3.44M

4,843

0.0031%

$233.82K

+89.3%

Kelderman Kim

Chief Executive Officer

—

$2.75M (8)

−$2.75M

82,762

0.0529%

$4.00M

+625.8%

Dinarello Charles A

Director

—

$2.12M (4) scheduled

−$2.12M

8,212

0.0052%

$396.48K

+25.2%

Seth Alpna

Director

—

$1.54M (2) scheduled

−$1.54M

15,411

0.0098%

$744.04K

+92.3%

HOLBROOK KAREN A

Director

—

$791.42K (3) scheduled

−$791.42K

914

0.0006%

$44.13K

−55.6%

Herr Amy E.

Director

—

$623.57K (4) scheduled

−$623.57K

3,256

0.0021%

$157.20K

+75.1%

LUCAS ROGER C

Director

—

$259.78K (16)

−$259.78K

1,870

0.0012%

$90.28K

−43.6%

Geist William

PRESIDENT, PROTEIN SCIENCES

—

24,943

0.0159%

$1.20M

+715.1%

KEEGAN JOSEPH D

Director

—

15,411

0.0098%

$744.04K

+92.3%

Vessey Rupert

Director

—

10,987

0.0070%

$530.45K

+134.0%

Bohnen Shane

SVP - General Counsel

—

10,360

0.0066%

$500.18K

+7,574%

Crouse Steven C.

President - Diag & Spatial Bi

—

10,237

0.0065%

$494.24K

+73.7%

Bushman Julie L

Director

—

8,775

0.0056%

$423.66K

+189.0%

McManus Matthew

President - Diag & Spatial Bio

—

7,691

0.0049%

$371.32K

—

Klimovsky Judith V.

Director

—

3,782

0.0024%

$182.59K

—

Gavin Robert M.

Sen. VP Protein Platforms

—

1,667

0.0011%

$80.48K

—

Gould Kevin S

SVP Clinical Controls

—

1,355

0.0009%

$65.42K

−18.7%

Bio-Techne

By person

Individual transactions

What was left out